Evidence map›Paper›PMID 27678522›Full record

ArticleG3 (Bethesda, Md.)2016

On Robust Association Testing for Quantitative Traits and Rare Variants.

Peng Wei, Ying Cao, Yiwei Zhang, Zhiyuan Xu, Il-Youp Kwak, Eric Boerwinkle, Wei Pan

Abstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Peng WeiDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 pwei2@mdanderson.org weip@biostat.umn.edu.
Ying CaoHuman Genetics Center, The University of Texas School of Public Health, Houston, Texas 77030.
Yiwei ZhangDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota 55455.
Zhiyuan XuDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota 55455.
Il-Youp KwakDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota 55455.
Eric BoerwinkleHuman Genetics Center, The University of Texas School of Public Health, Houston, Texas 77030.
Wei PanDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota 55455 pwei2@mdanderson.org weip@biostat.umn.edu.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Building on GWAS for NHLBI-disease: the CHARGE consortiumRC2HL102419 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A. · 2009 to 2010
$27.6M
Association analysis of rare variants with sequencing dataR01HL116720 · NHLBI · UNIVERSITY OF MINNESOTA · PI PAN, WEI, WEI, PENG · 2013 to 2020
$3.3M
Powerful Inference and Prediction for Genetic AssociationR01HL105397 · NHLBI · UNIVERSITY OF MINNESOTA · PI PAN, WEI, SHEN, XIAOTONG TOM · 2011 to 2018
$2.9M
New Machine Learning Tools for Biomedical DataR01GM081535 · NIGMS · UNIVERSITY OF MINNESOTA · PI PAN, WEI, SHEN, XIAOTONG TOM · 2007 to 2014
$2.2M
Genetic Susceptibility and Risk Model for Pancreatic CancerR01CA169122 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, PENG · 2013 to 2016
$1.1M
Statistical Methods for Genomic DataR01GM113250 · NIGMS · UNIVERSITY OF MINNESOTA · PI PAN, WEI · 2014 to 2017
$702k
Genome-wide gene-by-smoking interaction analysis of pulmonary functionR21HL126032 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MORRISON, ALANNA C, WEI, PENG · 2015 to 2017
$462k
NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA169122NHLBI NIH HHS R01 HL105397NHLBI NIH HHS R01 HL116720NHLBI NIH HHS R21 HL126032NHLBI NIH HHS RC2 HL102419NIGMS NIH HHS R01 GM081535NIGMS NIH HHS R01 GM113250
6 · The paper itself

Abstract

With the advance of sequencing technologies, it has become a routine practice to test for association between a quantitative trait and a set of rare variants (RVs). While a number of RV association tests have been proposed, there is a dearth of studies on the robustness of RV association testing for nonnormal distributed traits, e.g., due to skewness, which is ubiquitous in cohort studies. By extensive simulations, we demonstrate that commonly used RV tests, including sequence kernel association test (SKAT) and optimal unified SKAT (SKAT-O), are not robust to heavy-tailed or right-skewed trait distributions with inflated type I error rates; in contrast, the adaptive sum of powered score (aSPU) test is much more robust. Here we further propose a robust version of the aSPU test, called aSPUr. We conduct extensive simulations to evaluate the power of the tests, finding that for a larger number of RVs, aSPU is often more powerful than SKAT and SKAT-O, owing to its high data-adaptivity. We also compare different tests by conducting association analysis of triglyceride levels using the NHLBI ESP whole-exome sequencing data. The QQ plots for SKAT and SKAT-O were severely inflated (λ = 1.89 and 1.78, respectively), while those for aSPU and aSPUr behaved normally. Due to its relatively high robustness to outliers and high power of the aSPU test, we recommend its use complementary to SKAT and SKAT-O. If there is evidence of inflated type I error rate from the aSPU test, we would recommend the use of the more robust, but less powerful, aSPUr test.

Indexed as

Genetic Association StudiesGenetic VariationModels, GeneticQuantitative Trait, HeritableAlgorithmsComputer SimulationExomeGenome-Wide Association StudyHigh-Throughput Nucleotide SequencingHumansPhenotypePolymorphism, Single Nucleotideassociate testingnext-generation sequencingrare variantsrobustnessSKAT

Identifiers

PMID27678522
PMCPMC5144964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.